Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
1.
J Immunol Methods ; 478: 112722, 2020 03.
Article in English | MEDLINE | ID: mdl-31816281

ABSTRACT

In 2012, the FORS system was accepted by the International Society of Blood Transfusion as the 31st blood group system. Forssman (Fs) antigen (Ag) expression is most commonly found on sheep red blood cells (RBC) but rare in human RBC. Anti-Fs antibodies (Ab) are naturally occurring in human sera and are predominantly IgM but they can also be IgG. To this day, the global prevalence of the FORS system is unknown. Currently, there is a lack of natural FORS1-positive RBC available to use for anti-Fs screening in large populations. This study was designed to produce FORS1-positive cells viable for 40 days use in the anti-Fs screening. Three to 5% FORS1-positive cells were produced using sheep's blood and CellStab stabilizer solution. The quality of the FORS1-positive cells was investigated in more than three independent experiments of ABO titration, osmotic fragility test and supernatant haemolysis. For each batch of FORS1-positive cells produced, an extended antibody panel was performed. To demonstrate that the FORS1-positive cells can be used for up to 40 days, anti-Fs screening and classification were carried out in a patient and donor population. Antigenic expression and membrane integrity of FORS1-positive cells remained stable for 40 days. Good FORS1 Ag preservation was established, and minimal haemolysis was observed. In conclusion, a novel and easy-to-produce reagent has been developed and submitted to a patent with stable FORS1 Ag expression. With this FORS1-positive cell suspension, it is now possible to screen and classify anti-Fs Ab in large populations.


Subject(s)
Blood Group Antigens/isolation & purification , Blood Grouping and Crossmatching/methods , Erythrocytes/metabolism , Forssman Antigen/isolation & purification , Primary Cell Culture/methods , Animals , Blood Group Antigens/immunology , Cell Line , Cell Survival , Erythrocytes/immunology , Forssman Antigen/immunology , Forssman Antigen/metabolism , Humans , Sheep/blood , Sheep/immunology , Time Factors
2.
Blood Transfus ; 16(2): 178-183, 2018 02.
Article in English | MEDLINE | ID: mdl-27893352

ABSTRACT

BACKGROUND: In 1987, three unrelated English families were reported with a putative blood subgroup called Apae. Swedish researchers later found evidence leading to abolishment of the Apae subgroup and establishment instead of the FORS blood group system (System 31 - ISBT, 2012). It is important to know the prevalence of antibodies in order to make the best decisions in transfusion medicine. Cells expressing the Forssman saccharide, such as sheep erythrocytes, are needed to detect the anti-Forssman antibody. The aim of this study was to define the prevalence of human anti-Forssman antibody. MATERIALS AND METHODS: Plasma samples from 800 individuals were studied. Sheep erythrocytes or Forssman "kodecytes" were mixed with the plasma samples using the tube technique. Plasma from an Apae individual was used as a negative control and monoclonal anti-Forssman antibody (M1/22.25.8HL cell line supernatant) was used as the positive control. RESULTS: Of the 800 individuals tested, one was negative for the presence of anti-Forssman antibody. We compared the anti-Forssman antibody reaction pattern between genders and found that males have weaker reactions than females, both at room temperature (p=0.026) and at 37 °C (p=0.043). We also investigated the reaction pattern of anti-Forssman antibody in relation to ABO and Rh blood group types without finding any significant differences. DISCUSSION: Sheep erythrocytes are suitable for searching for human anti-Forssman antibody. The quantity of anti-Forssman antibodies in plasma is higher in females than in males. In the population (n=800) studied here, we found one individual lacking the anti-Forssman antibody. These results contribute to the data already published, confirming that FORS is a rare blood group.


Subject(s)
Blood Group Antigens/blood , Blood Grouping and Crossmatching/methods , Forssman Antigen/blood , Isoantibodies/blood , Oligosaccharides/blood , Animals , Blood Group Antigens/immunology , Female , Forssman Antigen/immunology , Humans , Isoantibodies/immunology , Male , Oligosaccharides/immunology , Prevalence , Sheep
3.
Transfusion ; 55(1): 129-36, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25039359

ABSTRACT

BACKGROUND: The FORS blood group system (originally recognized as the Apae phenotype) was discovered by sporadic activity against polyclonal anti-A reagents and activity against the lectin Helix pomatia. The extent of monoclonal anti-A reagent activity against the FORS1 antigen is serologically and immunochemically incomplete. STUDY DESIGN AND METHODS: In the absence of natural FORS1-positive red blood cells (RBCs), kodecytes were created with synthetic disaccharide and pentasaccharide Forssman function-spacer-lipid (FSL) constructs, Fsdi -kodecytes, and FORS1-kodecytes, respectively. FSL constructs were also applied to solid surfaces and used in solid-phase enzyme immunoassays. A range of characterized monoclonal anti-A and anti-B reagents were then serologically and immunochemically characterized against these Forssman antigens. Polyclonal human anti-A, anti-B, the lectin H. pomatia serologic reagents; and canine RBCs were used as serologic controls. RESULTS: None of 19 different monoclonal anti-A reagents were able to detect the pentasaccharide Forssman on FORS1-kodecytes, while three reagents were able to detect disaccharide Forssman on Fsdi -kodecytes. Most anti-A reagents were immunochemically reactive with both the di- and the pentasaccharide Forssman antigens in the solid-phase assays. Historic polyclonal human anti-A and the lectin H. pomatia reacted strongly with the FORS1-kodecytes, correlating with the discovery of the Apae phenotype and supporting the use of FORS1-kodecytes as FORS1 surrogates. CONCLUSIONS: Monoclonal anti-A reagents, despite showing reactivity against the FORS1 antigen in solid-phase assays are unlikely to cause the agglutination of FORS1 antigen-positive RBCs.


Subject(s)
Antibodies, Heterophile/immunology , Antibodies, Monoclonal/immunology , Forssman Antigen/analysis , Oligosaccharides/analysis , Animals , Antigen-Antibody Reactions , Carbohydrate Sequence , Disaccharides/immunology , Dogs , Erythrocyte Membrane/chemistry , Erythrocyte Membrane/immunology , Forssman Antigen/immunology , Globosides/immunology , Humans , Immunoenzyme Techniques , Lectins/immunology , Lipid Bilayers/chemistry , Membranes, Artificial , Molecular Sequence Data , Molecular Structure , Oligosaccharides/immunology , Phosphatidylethanolamines , Polysaccharides/immunology
4.
Xenotransplantation ; 17(3): 197-206, 2010.
Article in English | MEDLINE | ID: mdl-20636540

ABSTRACT

BACKGROUND: The continued presence of a primate antibody-mediated response to cells and organs from alpha1,3-galactosyltransferase gene-knockout (GTKO) pigs indicates that there may be antigens other than Gal alpha 1,3Gal (alpha Gal) against which primates have xenoreactive antibodies. Human and baboon sera were tested for reactivity against a panel of saccharides that might be potential antigen targets for natural anti-non-alpha Gal antibodies. METHODS: Human sera (n = 16) and baboon sera (n = 15) of all ABO blood types were tested using an enzyme-linked immunoadsorbent assay for binding of IgM and IgG to a panel of synthetic polyacrylamide-linked saccharides (n = 15). Human sera were also tested after adsorption on alpha Gal immunoaffinity beads. Sera from healthy wild-type (WT, n = 6) and GTKO (n = 6) pigs and from baboons (n = 4) sensitized to GTKO pig organ or artery transplants (of blood type O) were also tested. Forssman antigen expression on baboon and pig tissues was investigated by immunohistochemistry. RESULTS: Both human and baboon sera showed high IgM and IgG binding to alpha Gal saccharides, alpha-lactosamine, and Forssman disaccharide. Human sera also demonstrated modest binding to N-glycolylneuraminic acid (Neu5Gc). When human sera were adsorbed on alpha Gal oligosaccharides, there was a reduction in binding to alpha Gal and alpha-lactosamine, but not to Forssman. WT and GTKO pig sera showed high binding to Forssman, and GTKO pig sera showed high binding to alpha Gal saccharides. Baboon sera sensitized to GTKO pigs showed no significant increased binding to any specific saccharide. Staining for Forssman was negative on baboon and pig tissues. CONCLUSIONS: We were unable to identify definitively any saccharides from the selected panel that may be targets for primate anti-non-alpha Gal antibodies. The high level of anti-Forssman antibodies in humans, baboons, and pigs, and the absence of Forssman expression on pig tissues, suggest that the Forssman antigen does not play a role in the primate immune response to pigs.


Subject(s)
Antibodies/immunology , Antigens/immunology , Carbohydrates/immunology , Galactosyltransferases/genetics , Papio/immunology , Animals , Antibodies/blood , Antigens/chemistry , Carbohydrates/chemistry , Forssman Antigen/immunology , Galactosyltransferases/metabolism , Gene Knockdown Techniques , Humans , Mice , Oligosaccharides/chemistry , Oligosaccharides/metabolism , Papio/blood , Spleen/cytology , Spleen/immunology , Swine , Tissue Distribution
5.
Exp Oncol ; 29(1): 61-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17431391

ABSTRACT

UNLABELLED: Earlier we found two unusual IgG-antibody specificities to GalNAc beta and GalNAc beta1-3GalNAc beta (para-Forssman disaccharide, PFdi) carbohydrate ligands in human serum. The aim of the study was to evaluate whether elevated antibody levels are related to the progression of gastrointestinal cancer and the histopathological grading. METHODS: Specific IgG levels were tested in 159 patients with gastric cancer, 88 patients with colorectal cancer and 96 blood donors by the ELISA using synthetic polyacrylaamide (PAA) conjugates, GalNAc beta-PAA and PFdi-PAA. Biochemical and haematological analyses were performed using automatic equipment. RESULTS: The anti-PFdi IgG levels were significantly higher in patients with gastric and colorectal cancer than in donors: in stages II-IV, P = 0.0002 - 0.04 (U-test). The elevated anti-PFdi IgG level was associated with the advanced gastric cancer: in stages II, III, IV vs stage I (P = 0.004 - 0.06) and in case of the tumor size T2 + T3 vs T1 (stages I, II; P = 0.03). Differences in anti-GalNAc beta IgG level were insignificant. No relation between antibody levels and the regional and distant metastases of gastric or colorectal cancer was found. The lower anti-GalNAc beta IgG level was associated with lower-differentiated carcinomas (P = 0.01 - 0.04). Prolonged postoperative changes in the levels of both antibodies during the follow-up were established. An elevation of both antibody levels in patients with gastrointestinal cancer was revealed after a surgical removal of G3-tumors (P = 0.003 - 0.01). The anti-PFdi IgG levels correlated with the levels of the C-reactive protein: r = 0.50, P = 0.003. The anti-GalNAc beta IgG levels correlated with the percentage of peripheral blood monocytes: r = 0.42, P = 0.002. CONCLUSION: The association of the anti-PFdi IgG level with cancer progression suggests the implication of antibodies in the pathogenesis of gastrointestinal cancer. Further studies are required to identify natural targets of antibodies, their relation to other diseases, prognostic significance in cancer.


Subject(s)
Antibodies, Neoplasm/blood , Antigens, Tumor-Associated, Carbohydrate/immunology , Gastrointestinal Neoplasms/immunology , Globosides/immunology , Immunoglobulin G/blood , Adult , Aged , Antibody Formation , Antibody Specificity , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Forssman Antigen/immunology , Humans , Male , Middle Aged , Neoplasm Staging , Survival Rate
6.
Glycobiology ; 14(2): 115-26, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14638629

ABSTRACT

Neutral glycosphingolipids from sheep-derived Fasciola hepatica liver flukes were isolated and characterized both structurally and serologically. After HPLC fractionation, glycolipids were analyzed by linkage analysis, enzymatic cleavage, and MALDI-TOF as well as electrospray ionization mass spectrometry. Obtained results revealed the presence of two types of neutral glycolipids. The first group represented mammalian-type species comprising globo- and isoglobotriaosylceramides (Gal(alpha1-4)Gal(beta1-4)Glc(1-1)ceramide and Gal(alpha1-3)Gal(beta1-4)Glc(1-1)ceramide, respectively) as well as Forssman antigen (GalNAc(alpha1-3)GalNAc(beta1-3/4)Gal(alpha1-4/3)Gal(beta1-4)Glc(1-1)ceramide). Applying Helix pomatia agglutinin, recognizing terminal alpha-linked GalNAc, to cryosections of adult flukes, the latter glycolipid could be localized to the F. hepatica gut. As Forssman antigen from the parasite and sheep host led to identical MALDI-TOF MS profiles, this glycolipid might be acquired from the definitive host. As a second group, highly antigenic glycolipids were structurally characterized as Gal(beta1-6)Gal(beta1-4)Glc(1-1)ceramide, Gal(beta1-6)Gal(alpha1-3/4)Gal(beta1-4)Glc(1-1)ceramide and Gal(beta1-6)Gal(beta1-6)Gal(alpha1-3/4)Gal(beta1-4)Glc(1-1)ceramide, the latter two structures of which exhibited both isoglobo- or globo-series core structures. Terminal Gal(beta1-6)Gal1-motifs have previously been shown to represent antigenic epitopes of neogala-series glycosphingolipids from tape worms. Using human Echinococcus granulosus infection sera, Gal(beta1-6)Gal-terminating glycolipids could be allocated to the gut in adult liver fluke cryosections. Corresponding neogala-reactive antibodies in F. hepatica infection serum were detected by their binding to E. granulosus and Taenia crassiceps neogala-glycosphingolipids. These antibodies might contribute to the known serological cross-reactivity between F. hepatica and parasitic cestode infections.


Subject(s)
Cestode Infections/metabolism , Fasciola hepatica/chemistry , Glycolipids/chemistry , Animals , Carbohydrate Conformation , Carbohydrate Sequence , Cestode Infections/immunology , Cross Reactions , Fasciola hepatica/metabolism , Forssman Antigen/immunology , Glycosphingolipids/chemistry , Immunohistochemistry , Oligosaccharides/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
7.
J Cell Sci ; 116(Pt 22): 4533-42, 2003 Nov 15.
Article in English | MEDLINE | ID: mdl-14576347

ABSTRACT

5T4 oncotrophoblast antigen is a transmembrane glycoprotein expressed by trophoblast and many carcinomas but not most normal adult tissues. Results from overexpression of human and mouse 5T4 cDNA in cell lines are consistent with it having an influence on adhesion, shape and motility. We show that murine embryonic stem cell lines are 5T4 negative but that there is rapid up regulation of protein and transcripts upon differentiation, including derivatives of each primary germ layer, as evidenced by cell surface FACS, western and RT-PCR analyses. The kinetics of differentiation and 5T4 expression are closely correlated, with early events linking 5T4 expression to changes in motility and morphology. Comparison of 5T4 expression with other ES cell transcript (Oct 3/4; Rex-1) and antigen markers (Forsmann, SSEA-1) establishes 5T4 as a useful marker for the non-destructive detection of early differentiation of ES cells. For example, 'undifferentiated' ES phenotype defined as SSEA-1 positive and 5T4 negative is seven times more efficient at chimera formation than SSEA-1-positive/5T4-positive cells. Thus, 5T4 glycoprotein expression is associated with early differentiative events of ES cells involving altered motility, and it has useful practical consequences for assessing ES potency and studying similar processes in development and metastasis.


Subject(s)
Cell Differentiation/physiology , Membrane Glycoproteins/metabolism , Pluripotent Stem Cells/metabolism , Animals , Cell Movement/physiology , Cloning, Molecular , Fibroblasts/metabolism , Flow Cytometry , Forssman Antigen/immunology , Interleukin-6/metabolism , Leukemia Inhibitory Factor , Mice , Organic Cation Transport Proteins/metabolism , Pluripotent Stem Cells/cytology , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Trophoblasts/cytology , Trophoblasts/metabolism
8.
Immunology ; 110(1): 73-9, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12941143

ABSTRACT

Sh-CRIT-ed1 is a potent anti-complement peptide that inhibits the classical complement-activation pathway by interfering with the formation of the C3-convertase complex, C4b2a. C2 is an essential serum glycoprotein that provides the catalytic subunit of the C3 and C5 convertases of the classical pathways of complement activation. Because only in its C4-bound state is C2a capable of cleaving its physiological protein substrates C3 and C5, the interaction of Sh-CRIT-ed1 with C2 plays a decisive role of inhibition in the classical complement-activation process. However, the role of individual Sh-CRIT-ed1 amino acid residues in C2 binding is not fully understood. We constructed nine recombinant Sh-CRIT-ed1 (rSh1) analogues, substituted at conserved residues, and evaluated their anti-complement and C2-binding activities. Results from glutathione S-transferase (GST) pull-down and haemolytic assays suggested that residues 10K, 17E, 19K and 26Y are critical for the interaction of rSh1 with C2. We then constructed an improved anti-complement peptide by duplicating Sh-CRIT-ed1 C-terminal motifs (17H-26Y). This linear homodimer (rH17d) was more potent than rSh1 with respect to binding to C2 and anti-complement activity (the 50% inhibitory concentration value was approximately equal 1.2 micro m versus approximately equal 6.02 micro m for rSh1). Furthermore, rH17d showed higher anti-complement activity in vivo, providing additional evidence that this duplication is a more effective inhibitor of complement activation than rSh1. Taken together, these results identify four key residues in rSh1 and strongly suggest that rH17d is a potent inhibitor of complement activation that may have therapeutic applications.


Subject(s)
Antigens, Helminth/immunology , Complement Pathway, Classical/immunology , Helminth Proteins/immunology , Receptors, Cell Surface/immunology , Amino Acid Sequence , Animals , Antigens, Helminth/genetics , Complement C2/immunology , Complement C2/metabolism , Forssman Antigen/immunology , Guinea Pigs , Helminth Proteins/genetics , Hemolysis/immunology , Male , Molecular Sequence Data , Receptors, Cell Surface/genetics , Recombinant Proteins/immunology , Sequence Alignment , Shock/immunology , Structure-Activity Relationship
9.
Scand J Immunol ; 53(2): 121-31, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11169215

ABSTRACT

In the present study, the nature of hyperacute xenograft rejection was closely studied in a vascularized mouse-to-rat transplantation model. Antibodies against mouse heart, erythrocytes and lymphocytes and against the Forssman antigen were raised in the rat. Upon heterotopic heart transplantation the respective antisera were intravenously (i.v.) injected. Passive transfer of antiheart, antierythrocyte or antilymphocyte serum resulted in hyperacute rejection of the transplanted mouse heart. Subfractionation of the antiheart serum showed that the capacity to induce hyperacute rejection was carried by the immunoglobulin (Ig)G fraction. When antierythrocyte serum adsorbed with mouse erythrocytes was administered the cardiac grafts remained beating. To the contrary, antilymphocyte serum adsorbed with erythrocytes still had the capacity to induce hyperacute rejection. None of the rats that had previously been challenged with the Forssman antigen rejected their grafts hyperacutely. Subsequent investigations by electron microscopy revealed that the Forssman antigen is expressed on dendritic cells (DC) adjacent to the vessels, but not on the vascular endothelium, thus explaining the inability of the anti-Forssman serum to induce hyperacute rejection. Taken together, we have demonstrated the existence of several xenoantigens that can be targets for antibody-mediated rejection, suggesting that more than one relevant xenoantigen exists also in more distantly related combinations, such as the pig-to-human combination.


Subject(s)
Antibodies, Heterophile/immunology , Antigen-Antibody Reactions , Antigens, Heterophile/immunology , Aorta/immunology , Coronary Vessels/immunology , Endothelium, Vascular/immunology , Forssman Antigen/immunology , Heart Transplantation/immunology , Transplantation, Heterologous/immunology , Acute Disease , Animals , Antilymphocyte Serum/pharmacology , Aorta/pathology , Carbohydrate Sequence , Coronary Vessels/pathology , Dendritic Cells/immunology , Endothelium, Vascular/pathology , Erythrocytes/immunology , Glycolipids/immunology , Graft Rejection/immunology , Graft Rejection/pathology , Immunization , Immunization, Passive , Immunoglobulin G/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Microscopy, Electron , Molecular Sequence Data , Myocardium/immunology , Rats , Rats, Inbred Lew , Rats, Inbred Strains , Species Specificity , Transplantation, Heterotopic
10.
Transplantation ; 69(6): 1193-201, 2000 Mar 27.
Article in English | MEDLINE | ID: mdl-10762226

ABSTRACT

BACKGROUND: In the hamster-to-rat heart xenotransplantation model, the serum response of the host contributes to determine whether the xenograft is accommodated or rejected. METHODS: To further characterize the serum response in this model, we compared anti-hamster antibodies found in naive LEW-1A rats, or in LEW-1A rats rejecting or accommodating a hamster heart, using a combination of cobra venom factor (CVF) and cyclosporin A (CsA) given for 10 days, and then CsA alone. RESULTS: Hamster hearts grafted into rat recipients contained IgG and IgA deposits to the same extent whether the xenograft was rejected or accommodated. Only immunoglobulins of the IgM isotype were found to be more abundant in recipients rejecting their graft. A significant part of this IgM response was directed toward the Forssman antigen, a sphingolipid present in the hamster but not in the rat. However, although anti-Forssman antibodies bind in situ to hamster tissues, this binding was not able to induce hyperacute rejection after antibody transfer. Furthermore, depletion of anti-Forssman antibodies from a rejecting serum did not modify its rejection properties. CONCLUSION: Unlike the pig-to-primate discordant xenotransplantation model, in which preexisting anti-carbohydrate antibodies are directly responsible for hyperacute rejection, in the concordant hamster-to-rat situation, the evoked IgM anti-Forssman carbohydrate antibodies do not appear to be the main cause of the vascular rejection.


Subject(s)
Antibodies, Heterophile/immunology , Heart Transplantation , Transplantation, Heterologous , Animals , Antibody Formation , Cricetinae , Epithelial Cells/immunology , Forssman Antigen/immunology , Graft Rejection/immunology , Heart Transplantation/immunology , Immunoglobulin M/analysis , Lymphocytes/immunology , Myocardium/immunology , Rats
11.
Xenotransplantation ; 6(2): 90-7, 1999 May.
Article in English | MEDLINE | ID: mdl-10431785

ABSTRACT

The Forssman antigen has been proposed to be a target for the xenograft reaction in selected species combinations, including the rat and mouse, which are Forssman-negative and -positive species respectively. The mouse represents an important experimental model for a variety of immune-mediated disease processes, and the availability of a simple, inexpensive target antigen could provide an important tool for studying a selected portion of the immunologic basis for the rejection of xenografts. We have examined the potential that antibodies directed against mouse Forssman antigen could cause the hyperacute rejection of mouse heart xenografts in naive rat recipients. The Forssman antibodies tested included rat anti-mouse (R-anti-M) antiserum, R-anti-M antiserum depleted of anti-Forssman (anti-F) antibodies, rat anti-sheep red blood cell (SRBC) antiserum containing anti-F antibodies and a rat monoclonal anti-F IgM antibody. Our results demonstrate that the R-anti-M antiserum at day 4 post transplantation displayed significant titers (1:512-4096) of hemagglutinating antibodies for SRBC and mild to moderate levels of IgM that specifically binds to Forssman glycolipid (GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1- 4Glcbeta1-1ceramide) as measured by an enzyme-linked immunosorbent assay (ELISA). Passive transfer of the R-anti-M serum to rats receiving mouse cardiac grafts immediately after transplantation caused hyperacute rejection of the xenografts. Sequential immunoabsorption of R-anti-M sera with SRBCs resulted in total removal of the anti-Forssman activity (as defined by negative hemagglutination titer and minimal binding to Forssman glycolipid in ELISA). The anti-F Ab-depleted R-anti-M antisera, however, retained the capacity to induce hyperacute rejection of the mouse hearts [n = 6, median survival time (MST) 13 min] when passively transferred to rat recipients. Anti-Forssman antibodies induced by immunization of LEW rats with SRBCs or a rat anti-Forssman monoclonal antibody, mAb M.1.22.25, exhibited substantial anti-Forssman activity (hemagglutinating titer 1:512-4096 and moderate-to-strong binding to Forssman glycolipid in ELISA respectively). These antibodies also failed, however, to trigger hyperacute rejection of mouse cardiac xenografts. In conclusion, our results suggest that the rat anti-Forssman antibodies, including those stimulated by mouse cardiac xenografts, do not appear to play a role in the immediate (hyperacute) rejection of mouse heart xenografts.


Subject(s)
Forssman Antigen/immunology , Graft Rejection/immunology , Heart Transplantation , Transplantation Immunology , Animals , Antibodies/immunology , Mice , Rats , Transplantation, Heterologous
12.
Glycobiology ; 9(9): 875-86, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10460829

ABSTRACT

The heterophile antigens Galalpha1-->3Gal and N-glycolylneuraminic acid are the major obstacle to grafting mammal organs, especially from pig, to man. Lack of expression of these common xenoantigens by birds has raised interest in ostrich as a potential organ donor for xenotransplantation. Glycosphingolipids of ostrich liver and kidney were investigated for their carbohydrate determinants. Both organs were found similar in their glycolipid composition with three major species, mono-, di-, and pentaglycosylceramide. The pentaglycosylceramide was characterized as the Forssman antigen. In both organs, the ceramide portion was highly hydroxylated with prevalence of alpha-hydroxylated fatty acids, C18 phytosphingosine in kidney and C18 sphingosine in liver Forssman glycolipid. These data indicate that hydroxylation of kidney glycosphingolipids, which is found in mammals, has been maintained since the divergence of birds from other vertebrates. Characterization of a minor glycolipid as a Forssman tetraglycosylceramide built on the galabiosylceramide core indicates that the Forssman tetraglycosylceramide also exists in vivo. Its precursors, galactosyl- and galabiosylceramide, were characterized in kidney and liver. The Forssman antigen is the third heterophile antigen against which man raises natural antibodies. Its localization in the vascular endothelium and connective tissue makes ostrich an unpromising organ or cell donor for xenotransplantation to man.


Subject(s)
Cerebrosides/immunology , Forssman Antigen/immunology , Kidney/immunology , Liver/immunology , Struthioniformes/immunology , Animals , Carbohydrate Sequence , Mass Spectrometry , Molecular Sequence Data , Tissue Distribution , Transplantation, Heterologous
13.
Hybridoma ; 17(1): 55-62, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9523238

ABSTRACT

To study heterophile blood antigens on erythrocytes between human and experimental or domestic animals, we have produced 295 monoclonal antibodies (MAbs) to human erythrocyte membrane protein. According to the affinity, reactivity, and titre of the MAbs, we selected 40 clones to study the heterophile blood antigens between human and bovine, chicken, guinea pig, horse, rabbit, sheep, and swine. Five MAbs commonly reacted with human type A, type B, and type O erythrocytes and reacted with bovine erythrocytes as well but did not react with erythrocytes from other species. Other MAbs did not react with erythrocytes from all the tested animals. These five MAbs reacted with the same erythrocyte membrane protein, 90 KD glycophorin A (GPA) of human or 200 KD major glycoprotein and other two components of bovine by immunoblotting and GPA competitive inhibition assay. Furthermore, by enzyme treatment and monosaccharide competitive inhibition assay, it was confirmed that these five MAbs recognized antigen epitope of glycosylation free amino acid portion but not glycosylation portion of GPA of erythrocyte membrane.


Subject(s)
Antibodies, Monoclonal/immunology , Erythrocytes/immunology , Glycophorins/immunology , ABO Blood-Group System/immunology , Animals , Antibody Specificity , Cattle , Cross Reactions , Forssman Antigen/immunology , Guinea Pigs , Horses , Humans , Sheep , Species Specificity
15.
Transplantation ; 61(6): 957-63, 1996 Mar 27.
Article in English | MEDLINE | ID: mdl-8623166

ABSTRACT

Specificity of immune reactions has always been sought, because it facilitates intervention with unwanted mechanisms. Specific carbohydrate antigens have been proposed to be targets of antibodies in early immune responses in pig-to-man xenografts. This work was undertaken to determine carbohydrate structure for antibody response in the experimental xenograft model mouse-to-rat. Glycolipids were prepared from nine different mouse organs and separated for carbohydrate size on thin layer plates. Sera taken from normal untreated rats showed only weak or absent IgM antibody-binding to the separated mouse glycolipids. This is in accordance with the observation that mouse heart grafts are not hyperacutely rejected by the rat. However, sera taken from mouse heart xenografted rats show clear IgG and IgM antibody binding to neutral glycolipids migrating in the five-sugar region of the thin-layer plate. These rats have previously been reported to hyperacutely reject a second xenograft. Glycolipids with this particular mobility and immunostaining properties are the dominant ones in the mouse caval vein preparation, which probably represents a rather pure vascular structure. The target antigen structure was identified, by mass spectrometry and proton nuclear magnetic resonance spectroscopy, to be the Forssman pentaglycosylceramide. A commercial monoclonal antibody directed toward the Forssman antigen bound the same biochemical structure as the antibodies derived from the mouse heart-xenografted rats. Most of the IgM activity, but very little of the IgG activity was adsorbed using the Forssman terminal disaccharide solid phase.


Subject(s)
Antibodies/immunology , Carbohydrates/immunology , Forssman Antigen/immunology , Glycolipids/immunology , Glycolipids/metabolism , Graft Rejection/immunology , Heart Transplantation/immunology , Acute Disease , Amino Acid Sequence , Animals , Antibodies/metabolism , Antigen-Antibody Reactions , Blood , Carbohydrate Sequence , Chromatography, Thin Layer , Dogs , Immunohistochemistry , Male , Mice , Mice, Inbred Strains , Molecular Sequence Data , Rats , Rats, Inbred Lew , Transplantation, Heterologous
16.
Am J Pathol ; 146(5): 1260-72, 1995 May.
Article in English | MEDLINE | ID: mdl-7747818

ABSTRACT

Forssman antigen is a glycosphingolipid with antigenic specificity determined by extra-membrane haptenic sugars similar to blood group antigens and antigens that are the main barrier to xenogeneic organ transplantation. Herein, we describe the localization of Forssman antigen in guinea pig lungs and kidneys and the consequences of its interaction with antibodies in vitro and in vivo (Forssman reaction). Exposure of cultured guinea pig aortic endothelial cells to Forssman antibodies induced rapid redistribution of antigen-antibody complexes at the cell surface, followed by shedding that occurred by blebbing of plasma membrane as vesicles or fragments, and was associated with disappearance of antigen from the cell surface (antigenic modulation). Guinea pigs surviving frequent intravenous infections of increasing amounts of antibodies, for a total of 20 to 40 lethal doses, developed a partial or complete adaptation to generalized Forssman reaction, and adaptation was associated with partial or complete modulation of Forssman antigen at the surface of the pulmonary and, in minor degree, renal endothelial and epithelial cells. These findings support the hypothesis that modulation of endothelial carbohydrate antigens contributes to adaptation of highly vascularized organs exposed to tolerable levels of allo- or xenoantibodies.


Subject(s)
Forssman Antigen/analysis , Immune Sera/immunology , Immune Tolerance/immunology , Kidney/immunology , Lung/immunology , Animals , Aorta/cytology , Blotting, Western , Cells, Cultured , Complement Activation/immunology , Electrophoresis, Polyacrylamide Gel , Endothelium, Vascular/immunology , Female , Forssman Antigen/immunology , Guinea Pigs , Kidney/pathology , Lung/pathology
17.
J Cell Sci ; 107 ( Pt 9): 2471-82, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7844164

ABSTRACT

Amastigotes of the protozoan parasite Leishmania proliferate in phagolysosomes of macrophages. They abundantly express glycoinositol phospholipids (GIPLs), which are considered necessary for parasite survival by providing a shield at the surface against lysosomal hydrolases and by serving as receptors for the interaction with host cells. The structures of four GIPLs of L. mexicana amastigotes were characterized by a combination of gas-liquid chromatography-mass spectrometry, methylation linkage analysis and enzymatic treatments. They contain the glycan structures Man alpha 1-3Man alpha 1-4GlcN (iM2), Man alpha 1-6(Man alpha 1-3)Man alpha 1-4GlcN (iM3), Man alpha 1-2Man alpha 1-6(Man alpha 1-3)-Man alpha 1-4GlcN (iM4) and (NH2-CH2CH2-PO4)Man alpha 1-6(Man alpha 1-3)Man alpha 1-4GlcN (EPiM3), which are linked to alkylacyl-phosphatidylinositol. The predominant amastigote GIPL, EPiM3 (approximately 2 x 10(7) molecules/cell), is located at the parasite cell surface, in the flagellar pocket and in lysosomal membranes, but not on host cell structures as shown by immunofluorescence and immunoelectron microscopy. In addition, amastigotes in infected Balb/c mice contain a glycolipid with similar distribution as EPiM3, which has the same characteristics as the Forssman antigen of mammalian cells. In contrast to EPiM3, there is strong evidence that this glycosphingolipid is not synthesized by amastigotes but by macrophages in the lesion. This suggests a mechanism of lipid transfer from the macrophage to the parasite.


Subject(s)
Antigens, Protozoan/immunology , Antigens, Surface/immunology , Forssman Antigen/immunology , Glycolipids/immunology , Glycosphingolipids/immunology , Glycosylphosphatidylinositols/immunology , Leishmania mexicana/immunology , Macrophages/immunology , Phospholipids/immunology , Animals , Antigens, Protozoan/biosynthesis , Antigens, Protozoan/chemistry , Antigens, Surface/biosynthesis , Antigens, Surface/chemistry , Carbohydrate Sequence , Forssman Antigen/metabolism , Glycolipids/biosynthesis , Glycolipids/chemistry , Glycosphingolipids/metabolism , Glycosylphosphatidylinositols/chemistry , Leishmania mexicana/growth & development , Macrophages/metabolism , Macrophages/parasitology , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Microscopy, Immunoelectron , Molecular Sequence Data , Phosphatidylinositol Diacylglycerol-Lyase , Phosphoric Diester Hydrolases/metabolism
18.
Glas Srp Akad Nauka Med ; (44): 109-16, 1994.
Article in Serbian | MEDLINE | ID: mdl-7590407

ABSTRACT

According to experimental data, administration of interferon in mice before contact with antigen reduced antibody response, while its presence after antigen load enhanced them. The aim of this study was to detect possible immunomodulatory effects of unpurified human alpha-interferon on izohemagglutinin (IZO), and anti-Forssman antibody (AFA) serum levels during a treatment in patients with malignant melanoma. Fifty-two patients treated with the same chemotherapy regimen (ADM-VCR-CPM-DTIC-PCB) entered the study; 30 received INF 1.000.000 U/24 h x 10 during each cycle, intercycle interval 4 weeks. Twenty-two did not receive interferon. Initial IZO titers were 1/4-1/256, median 1/64, and for AFA 0-1/14, median 1/7. Following 4 cycles, values for IZO titers were: in the IFN group 1/32-1/262.144, median 1/128; in the non-IFN group range 1/8-1/512, median 1/32. The values for AFA titers were: in the INF group 0-1/442, median between 1/28 and 1/56; in control group 0-1/112, median 1/14. The difference between both median values for the INF group and initial median values was statistically significant. Initial elevation of titers was reversed during a few cycles with both A and B substances and the Forssman antigen, immunisation of humans is permanent. It would be of interest to ascertain effects of interferons on antibody response to others antigens, especially bacterial and viral, during aggressive chemotherapy. In any case, both experimentally observed phenomena seem to occur in vivo during interferon treatment of metastatic melanoma.


Subject(s)
Antibodies/analysis , Forssman Antigen/immunology , Hemagglutinins/analysis , Interferon-alpha/therapeutic use , Melanoma/immunology , Melanoma/secondary , Humans , Interferon alpha-2 , Melanoma/blood , Melanoma/therapy , Recombinant Proteins
19.
Eur J Cell Biol ; 56(2): 269-85, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1802714

ABSTRACT

We have studied the surface distribution of a glycosphingolipid (the Forssman antigen) in MDCK II and CCL39 cells. The Forssman antigen is mobile on the surface of both these cell lines. Its surface distribution is homogenous on non-polarized cells. Under conditions where MDCK II cells are well polarized, the Forssman antigen is present in equal amounts on the apical membrane and on the basal membrane and its processes. Very little Forssman antigen can be detected on the lateral membrane. The nature of the mechanism excluding the Forssman antigen from the lateral domain remains to be determined. This surface distribution is established within hours after plating and was observed with cells grown on different types of filters. The surface density of the Forssman antigen on the apical and on the basal domain has been estimated. No involvement of the basal Forssman antigen in cell attachment could be demonstrated. However, the apical Forssman antigen appears to be essential to the establishment of the cells in culture.


Subject(s)
Cell Adhesion/physiology , Cell Polarity/physiology , Forssman Antigen/analysis , Glycosphingolipids/analysis , Animals , Cell Line , Cricetinae , Dogs , Fibroblasts/cytology , Forssman Antigen/immunology , Glycosphingolipids/immunology , Immunoenzyme Techniques , Immunohistochemistry , Kidney/cytology , Microscopy, Fluorescence
20.
Clin Exp Immunol ; 86(3): 483-8, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1747956

ABSTRACT

Sera from patients with Graves' disease and Hashimoto's thyroiditis have been shown to react with the Forssman glycolipid antigen (Gb5) using the techniques of high performance thin-layer chromatography (HPTLC) immunostaining and ELISA. Human monoclonal antibodies (MoAbs) have been prepared by fusion of human myeloma with peripheral lymphocytes from patients with Graves' disease. A MoAb, TRMo-4, reacted strongly and specifically with Gb5. These results suggest that anti-Forssman antibody may be involved in the pathogenesis of these autoimmune diseases. The detection of anti-Forssman glycolipid antibody may provide a useful means for clinical diagnosis and therapy.


Subject(s)
Autoantibodies/analysis , Forssman Antigen/immunology , Globosides/immunology , Graves Disease/immunology , Thyroiditis, Autoimmune/immunology , Antibodies, Monoclonal , Antigen-Antibody Reactions , Ceramides/immunology , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay , Gangliosides/immunology , Humans , Immunoglobulin G/analysis , Receptors, Thyrotropin , Recombinant Fusion Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...